Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Satisfaction × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 27 Carcinoma, Basal Cell 12 Uterine Cervical Dysplasia 11 Melanoma 7 Glioma 4 Glioblastoma 4 Condylomata Acuminata 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Papillomavirus Infections 3 Keratosis 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Precancerous Conditions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Hutchinson's Melanotic Freckle 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Surveys and Questionnaires 3 delta 24-sterol reductase 2 Urinary Diversion 2 Surgical Procedures, Operative 2 Propofol 2 daratumumab 1 Vascular Access Devices 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Pilot Projects 1 Patient Transfer 1 Parapsychology 1 Music Therapy 1 Midazolam 1 Mastectomy, Segmental 1 Lidocaine 1 Imiquimod 1 Ibuprofen 1 Fentanyl 1 Exercise 1 Drainage 1 Cystectomy 1 Control Groups 1 Colonoscopy 1 Bandages, Hydrocolloid 1 Ambulatory Care 1 Alfentanil 1 Aftercare 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861535 2021-04-14

PITVIN

Medical University of Graz

Phase 3 Completed

Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡